1. P21‐activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells. Issue 5 (23rd February 2017) Authors: Babagana, Mahamat; Johnson, Sydney; Slabodkin, Hannah; Bshara, Wiam; Morrison, Carl; Kandel, Eugene S. Journal: Molecular carcinogenesis Issue: Volume 56:Issue 5(2017) Page Start: 1515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The role of polo‐like kinase 3 in the response of BRAF‐mutant cells to targeted anticancer therapies. Issue 1 (30th September 2019) Authors: Babagana, Mahamat; Kichina, Julia V.; Slabodkin, Hannah; Johnson, Sydney; Maslov, Alexei; Brown, Lorin; Attwood, Kristopher; Nikiforov, Mikhail A.; Kandel, Eugene S. Journal: Molecular carcinogenesis Issue: Volume 59:Issue 1(2020) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗